People with stable pulmonary arterial hypertension (PAH) can safely switch from Tracleer (bosentan) to Letairis (ambrisentan) without…
Articles by Vanda Pinto, PhD
A study of rare gene variants has identified two new candidates — fibulin 2 (FBLN2) and platelet-derived growth factor D…
Trifluoperazine or TFP, an approved schizophrenia medication, also may be effective in the treatment of pulmonary arterial hypertension…
Intermediate-risk pulmonary arterial hypertension (PAH) patients may see their symptoms improve after switching from phosphodiesterase-5 inhibitors (PDE-5i) to…
Several proteins involved in vascular remodeling, metabolism, and oxidative stress are not properly regulated in endothelial cells from patients with…
Women who reach menopause prematurely — meaning before age 40 — are two times more likely to develop pulmonary hypertension…
A six-month exercise training program can significantly improve physical and psychological well-being in patients with pulmonary hypertension (PH), according…